CPRX - Catalyst Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CPRX is currently covered by 5 analysts with an average price target of $31.98. This is a potential upside of $8.31 (35.11%) from yesterday's end of day stock price of $23.67.

Catalyst Pharmaceuticals's activity chart (see below) currently has 84 price targets and 87 ratings on display. The stock rating distribution of CPRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 82.14% with an average time for these price targets to be met of 559.33 days.

Highest price target for CPRX is $35, Lowest price target is $30, average price target is $30.4.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 26-Apr-2016.

Currently out of the existing stock ratings of CPRX, 21 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$35

$11.47 (48.75%)

$35

3 months 19 days ago
(28-Feb-2025)

10/14 (71.43%)

$12.11 (52.91%)

505

Buy

$30

$6.47 (27.50%)

$23

5 months 8 days ago
(08-Jan-2025)

1/2 (50%)

$7.2 (31.58%)

245

Buy

$29

$5.47 (23.25%)

$29

1 years 10 days ago
(06-Jun-2024)

5/7 (71.43%)

$13.24 (84.01%)

930

Buy

$34

$10.47 (44.50%)

$27

1 years 3 months 15 days ago
(01-Mar-2024)

9/12 (75%)

$16.99 (99.88%)

761

Buy

$24

$6.99 (41.09%)

$22

1 years 11 months 27 days ago
(20-Jun-2023)

5/7 (71.43%)

$11.38 (90.17%)

408

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CPRX (Catalyst Pharmaceuticals) average time for price targets to be met?

On average it took 559.33 days on average for the stock forecasts to be realized with a an average price target met ratio 82.14

Which analyst has the current highest performing score on CPRX (Catalyst Pharmaceuticals) with a proven track record?

ANDREW FEIN

Which analyst has the current lower performing score on CPRX (Catalyst Pharmaceuticals) with a proven track record?

JASON GERBERRY

Which analyst has the most public recommendations on CPRX (Catalyst Pharmaceuticals)?

Andrew Fein works at HC WAINWRIGHT and has 22 price targets and 18 ratings on CPRX

Which analyst is the currently most bullish on CPRX (Catalyst Pharmaceuticals)?

Andrew Fein with highest potential upside - $11.47

Which analyst is the currently most reserved on CPRX (Catalyst Pharmaceuticals)?

Edward Nash with lowest potential downside - -$13.53

Catalyst Pharmaceuticals in the News

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Release Date: May 08, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) reported a 43.6% year-over-year increase in total net revenues, reaching $141.4 million. The company maintains a strong cash position of $580.7 million, supporting long-term growth and strategic priorities....

Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know

Wall Street expects a year-over-year increase in earnings on higher revenues when Xencor (XNCR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company’s earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?